These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16008161)

  • 1. A reassessment of the Lewy body.
    Au WL; Calne DB
    Acta Neurol Taiwan; 2005 Jun; 14(2):40-7. PubMed ID: 16008161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
    Taylor JP; Mata IF; Farrer MJ
    Trends Mol Med; 2006 Feb; 12(2):76-82. PubMed ID: 16406842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology.
    Jackson LM; Woodruff BK; Tremblay C; Shill HA; Beach TG; Serrano GE; Adler CH
    Mov Disord Clin Pract; 2024 Jul; 11(7):874-878. PubMed ID: 38757351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
    Zimprich A; Biskup S; Leitner P; Lichtner P; Farrer M; Lincoln S; Kachergus J; Hulihan M; Uitti RJ; Calne DB; Stoessl AJ; Pfeiffer RF; Patenge N; Carbajal IC; Vieregge P; Asmus F; Müller-Myhsok B; Dickson DW; Meitinger T; Strom TM; Wszolek ZK; Gasser T
    Neuron; 2004 Nov; 44(4):601-7. PubMed ID: 15541309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Parkinson's disease.
    Morris HR
    Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.
    Funayama M; Hasegawa K; Ohta E; Kawashima N; Komiyama M; Kowa H; Tsuji S; Obata F
    Ann Neurol; 2005 Jun; 57(6):918-21. PubMed ID: 15880653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.
    Devine MJ; Lewis PA
    FEBS J; 2008 Dec; 275(23):5748-57. PubMed ID: 19021752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.
    Higashi S; Biskup S; West AB; Trinkaus D; Dawson VL; Faull RL; Waldvogel HJ; Arai H; Dawson TM; Moore DJ; Emson PC
    Brain Res; 2007 Jun; 1155():208-19. PubMed ID: 17512502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy bodies in Parkinson's disease: protectors or perpetrators?
    Harrower TP; Michell AW; Barker RA
    Exp Neurol; 2005 Sep; 195(1):1-6. PubMed ID: 16023637
    [No Abstract]   [Full Text] [Related]  

  • 13. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K; Takahashi H
    Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 protein is a component of Lewy bodies.
    Zhu X; Siedlak SL; Smith MA; Perry G; Chen SG
    Ann Neurol; 2006 Nov; 60(5):617-618. PubMed ID: 16847950
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Mov Disord; 1999 Jan; 14(1):6-9. PubMed ID: 9918338
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease and other alpha-synucleinopathies.
    Goedert M
    Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?
    Inzelberg R; Polyniki A
    J Neurol Sci; 2010 Feb; 289(1-2):23-6. PubMed ID: 19740488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.